Inflation reaching multi-decade highs, uncertainty in the banking world and credit markets drying up dampened private equity health care M&A activity in 2022, especially in the second half. Many anticipate that investment slowdown to continue into 2023, but there’s a good chance the home health industry will buck that trend, reports Home Health Care News.
Multiple PE firms, such as Shore Capital Partners, Health Enterprise Partners (HEP) and Sheridan Capital Partners, appear to believe that notion at least. Read more.
